Biology and Treatment of High-Risk CLL: Significance of Complex Karyotype.

Front Oncol · 2021 · PMC8667220 · PMID 34912723

Europe PMC DOI

hedged sentence

0.2900

closest p · 5.8× alpha

0.2900

boldest claim

The sentences

showed a trendp = 0.29not close (p > 0.1)

Additionally, patients with high-CK showed a trend towards worse PFS versus those with fewer abnormalities (HR, 1.5; 95% CI, 0.7 to 3.4; p = 0.29). he role of CK in venetoclax-based combination was also assessed in treatment-naïve patients following therapy with venetoclax–obinutuzumab (VenG) or cholambucil–obinutuzumab (ClbG) within the CLL14 trial ( 38 ).

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.